Articles related to NEUROLOGICAL DISORDERS

Manifest Technologies is spearheading the use of AI in developing targeted treatments for CNS disorders, aiming to refine patient selection in clinical trials and enhance therapeutic outcomes.

Physicians should be acutely aware of the heightened risk of neuroinvasive arboviral infections in patients treated with rituximab, necessitating a shift towards molecular diagnostic testing for timely and accurate detection.

Advanced biological aging, as measured by clinical biomarkers, increases one’s risk for dementia or stroke, despite adjustment for disease-specific risk factors. This finding underscores the potential of biological age as a predictor of neurological health.

Healthcare professionals should be aware of the potential for neurological side effects in patients receiving COVID-19 vaccines. With nearly one-third of vaccine recipients experiencing symptoms such as headaches, tremors, and insomnia, continued monitoring and research are crucial.

Recent findings suggest that Candida albicans, a common fungus, can enter the brain and generate toxic protein fragments similar to those seen in Alzheimer’s disease. This discovery could potentially open new avenues for understanding and treating Alzheimer’s.

Explore how prioritizing gut health may offer a head start advantage in combating neurodegenerative diseases.